Janet Daltner, CRNP

NPI: 1780025528
Total Payments
$472.37
2024 Payments
$121.98
Companies
7
Transactions
27
Medicare Patients
165
Medicare Billing
$14,119

Payment Breakdown by Category

Food & Beverage$472.37 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $472.37 27 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $208.84 12 $0 (2024)
Janssen Pharmaceuticals, Inc $159.00 8 $0 (2024)
AstraZeneca Pharmaceuticals LP $32.29 2 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $29.90 2 $0 (2021)
Amgen Inc. $14.93 1 $0 (2021)
Kowa Pharmaceuticals America, Inc. $14.15 1 $0 (2021)
Boston Scientific Corporation $13.26 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $121.98 6 Janssen Pharmaceuticals, Inc ($62.59)
2023 $82.67 5 E.R. Squibb & Sons, L.L.C. ($46.27)
2022 $134.29 7 E.R. Squibb & Sons, L.L.C. ($74.28)
2021 $133.43 9 E.R. Squibb & Sons, L.L.C. ($42.16)

All Payment Transactions

27 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/21/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $32.14 General
Category: Cardiovascular & Metabolism
08/08/2024 Boston Scientific Corporation BodyGuardian (Device) Food and Beverage In-kind items and services $13.26 General
Category: CDS - Holter Monitoring_RM
07/01/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $27.84 General
Category: Cardiovascular
06/06/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.91 General
Category: Cardiovascular & Metabolism
02/08/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.54 General
Category: Cardiovascular & Metabolism
01/26/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $18.29 General
Category: Cardiovascular
09/27/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.00 General
Category: Cardiovascular & Metabolism
08/22/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.25 General
Category: Cardiovascular
06/27/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.09 General
Category: Cardiovascular
05/08/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.40 General
Category: Cardiovascular & Metabolism
03/21/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.93 General
Category: Cardiovascular
09/08/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $19.46 General
Category: Cardiovascular
08/03/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $16.74 General
Category: Cardiovascular
05/27/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.19 General
Category: Cardiovascular & Metabolism
05/02/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.05 General
Category: Cardiovascular & Metabolism
04/25/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $20.68 General
Category: Cardiovascular
04/06/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.77 General
Category: Cardiovascular & Metabolism
03/22/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $17.40 General
Category: Cardiovascular
09/21/2021 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.55 General
Category: Cardio-renal
08/24/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $11.76 General
Category: Cardiovascular
08/18/2021 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.93 General
Category: Cardiology
08/16/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Bystolic Food and Beverage Cash or cash equivalent $14.15 General
Category: Cardiovascular
08/13/2021 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.35 General
Category: Cardio-renal
08/11/2021 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.98 General
Category: Cardiovascular and Metabolism
06/24/2021 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.31 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 57 65 $10,159 $4,096
2021 3 63 63 $11,434 $6,014
2020 3 45 50 $9,110 $4,008
Total Patients
165
Total Services
178
Medicare Billing
$14,119
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 28 34 $4,182 $1,756 42.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 14 16 $2,512 $1,243 49.5%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 15 15 $3,465 $1,097 31.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 20 20 $3,880 $2,313 59.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 28 28 $4,284 $2,246 52.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $3,270 $1,456 44.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 16 17 $4,571 $2,097 45.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 16 16 $2,448 $1,090 44.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 13 17 $2,091 $822.13 39.3%

About Janet Daltner, CRNP

Janet Daltner, CRNP is a Nurse Practitioner healthcare provider based in Wexford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1780025528.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janet Daltner, CRNP has received a total of $472.37 in payments from pharmaceutical and medical device companies, with $121.98 received in 2024. These payments were reported across 27 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($472.37).

As a Medicare-enrolled provider, Daltner has provided services to 165 Medicare beneficiaries, totaling 178 services with total Medicare billing of $14,119. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Wexford, PA
  • Active Since 07/09/2013
  • Last Updated 07/09/2013
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1780025528

Products in Payments

  • XARELTO (Drug) $159.00
  • ELIQUIS (Drug) $156.71
  • CAMZYOS (Drug) $52.13
  • FARXIGA (Drug) $32.29
  • Kerendia (Drug) $29.90
  • Repatha (Biological) $14.93
  • Livalo (Drug) $14.15
  • BodyGuardian (Device) $13.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Wexford